Methylenedioxybutylamphetamine  |
| Names |
| IUPAC name N-[1-(1,3-Benzodioxol-5-yl)propan-2-yl]butan-1-amine |
| Identifiers |
| | |
3D model (JSmol) | |
| ChemSpider | |
| | |
| | |
InChI InChI=1S/C14H21NO2/c1-3-4-7-15-11(2)8-12-5-6-13-14(9-12)17-10-16-13/h5-6,9,11,15H,3-4,7-8,10H2,1-2H3 Key: RDXVRDCQDITVDV-UHFFFAOYSA-N
|
SMILES C1=C2C(=CC=C1CC(C)NCCCC)OCO2
|
| Properties |
Chemical formula | C14H19NO2 |
| Molar mass | 233.311 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). |
| | |
Methylenedioxybutylamphetamine (MDBU or 3,4-methylenedioxy-N-butylamphetamine) is a lesser-known psychedelic drug. It is also the N-butyl derivative of 3,4-methylenedioxyamphetamine (MDA). MDBU was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 40 mg, and the duration unknown.[1] MDBU produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDBU.
See also
References
This article is copied from an
article on Wikipedia® - the free encyclopedia created and edited by its online user community. The text was not checked or edited by anyone on our staff. Although the vast majority of Wikipedia® encyclopedia articles provide accurate and timely information, please do not assume the accuracy of any particular article. This article is distributed under the terms of
GNU Free Documentation License.
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.
)